Endoscopy 2020; 52(01): 68-72
DOI: 10.1055/a-1008-9077
Innovations and brief communications
© Georg Thieme Verlag KG Stuttgart · New York

Full-thickness resection of neuroendocrine tumors in the rectum

Benjamin Meier
1   Department of Gastroenterology, Klinikum Ludwigsburg, Ludwigsburg, Germany
,
Heinz Albrecht
2   Department of Gastroenterology, Klinikum Neumarkt, Neumarkt in der Oberpfalz, Germany
,
Thomas Wiedbrauck
3   Department of Gastroenterology, Malteser Krankenhaus St. Anna, Duisburg, Germany
,
Arthur Schmidt
4   Department of Medicine II, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany
,
Karel Caca
1   Department of Gastroenterology, Klinikum Ludwigsburg, Ludwigsburg, Germany
› Author Affiliations
Further Information

Publication History

submitted: 10 December 2018

accepted after revision: 09 August 2019

Publication Date:
15 October 2019 (online)

Abstract

Background Rectal neuroendocrine tumors (NETs) are subepithelial tumors with potential for malignancy. Depending on tumor characteristics, endoscopic or surgical resection is recommended. However, the optimal endoscopic approach is not defined. This is the first larger study evaluating endoscopic full-thickness resection (EFTR) of rectal NETs.

Methods For resection, the full-thickness resection device (FTRD) was used. A registry was created as part of post-market clinical follow-up. All cases of rectal NETs in the registry were analyzed retrospectively.

Results 31 German centers entered data of 501 FTRD procedures and 40 cases of rectal NETs were identified. The median lesion size was 8 mm. All lesions could be resected using FTRD. The median procedure time was 18.5 minutes. Resection was macroscopically and histologically complete in all cases. Full-thickness resection was achieved in 95 %. No major adverse events occurred. Endoscopic follow-up showed no evidence of residual or recurrent tumor.

Conclusion EFTR is safe and effective for resection of smaller rectal NETs. Prospective comparative trials are needed to define the role of EFTR of rectal NETs.

 
  • References

  • 1 Chablaney S, Zator ZA, Kumta NA. Diagnosis and management of rectal neuroendocrine tumors. Clin Endosc 2017; 50: 530-536
  • 2 Nakamura K, Osada M, Goto A. et al. Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification. Scand J Gastroenterol 2016; 51: 448-455
  • 3 Chen T, Yao LQ, Xu MD. et al. Efficacy and safety of endoscopic submucosal dissection for colorectal carcinoids. Clin Gastroenterol Hepatol 2016; 14: 575-581
  • 4 Qi ZP, Shi Q, Liu JZ. et al. Efficacy and safety of endoscopic submucosal dissection for submucosal tumors of the colon and rectum. Gastrointest Endosc 2018; 87: 540-548
  • 5 Schmidt A, Beyna T, Schumacher B. et al. Colonoscopic full-thickness resection using an over-the-scope device: a prospective multicentre study in various indications. Gut 2018; 67: 1280-1289
  • 6 Richter-Schrag HJ, Walker C, Thimme R. et al. [Full thickness resection device (FTRD). Experience and outcome for benign neoplasms of the rectum and colon]. Chirurg 2016; 87: 316-325
  • 7 Valli PV, Mertens J, Bauerfeind P. Safe and successful resection of difficult GI lesions using a novel single-step full-thickness resection device (FTRD (R)). Surg Endosc 2018; 32: 289-299
  • 8 Aepli P, Criblez D, Baumeler S. et al. Endoscopic full thickness resection (EFTR) of colorectal neoplasms with the Full Thickness Resection Device (FTRD): clinical experience from two tertiary referral centers in Switzerland. United European Gastroenterol J 2018; 6: 463-470
  • 9 Kim J, Kim JH, Lee JY. et al. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor. BMC Gastroenterol 2018; 18: 77
  • 10 Zhong DD, Shao LM, Cai JT. Endoscopic mucosal resection vs endoscopic submucosal dissection for rectal carcinoid tumours: a systematic review and meta-analysis. Colorectal Dis 2013; 15: 283-291
  • 11 Ebi M, Nakagawa S, Yamaguchi Y. et al. Endoscopic submucosal resection with an endoscopic variceal ligation device for the treatment of rectal neuroendocrine tumors. Int J Colorectal Dis 2018; 33: 1703-1708
  • 12 Yang DH, Park Y, Park SH. et al. Cap-assisted EMR for rectal neuroendocrine tumors: comparisons with conventional EMR and endoscopic submucosal dissection (with videos). Gastrointest Endosc 2016; 83: 1015-1022
  • 13 Pan J, Zhang X, Shi Y. et al. Endoscopic mucosal resection with suction vs. endoscopic submucosal dissection for small rectal neuroendocrine tumors: a meta-analysis. Scand J Gastroenterol 2018; 53: 1139-1145
  • 14 Azzolini F, Cecinato P, Iori V. et al. Endoscopic full-thickness resection for suspected residual rectal neuroendocrine tumor and closure of the defect with a new suturing system. Endoscopy 2015; 47 (Suppl. 01) E556-E557
  • 15 Grauer M, Gschwendtner A, Schafer C. et al. Resection of rectal carcinoids with the newly introduced endoscopic full-thickness resection device. Endoscopy 2016; 48 (Suppl. 01) E123-E124